COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience.

Preziosa, Paolo; Rocca, Maria A; Nozzolillo, Agostino; Moiola, Lucia; Filippi, Massimo

Preziosa, Paolo; Rocca, Maria A; Nozzolillo, Agostino; Moiola, Lucia; Filippi, Massimo.

Preziosa P; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Rocca MA; Neurology Unit, IRCCS San Rafaele Scientiic Institute, Milan, Italy.
Nozzolillo A; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Moiola L; Neurology Unit, IRCCS San Rafaele Scientiic Institute, Milan, Italy.
Filippi M; Vita-Salute San Raffaele University, Milan, Italy.

J Neurol ; 268(8): 2697-2699, 2021 Aug.

Article in English | MEDLINE | ID: covidwho-935251

Subject(s)

COVID-19; Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Cladribine/therapeutic use; Humans; Immunosuppressive Agents/therapeutic use; Multiple Sclerosis, Relapsing-Remitting/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / COVID-19 / Multiple Sclerosis Limits: Humans Language: English Journal: J Neurol Year: 2021 Document Type: Article Affiliation country: S00415-020-10309-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google